Is Zepbound Worth It? Verified 2026 Cost, Real Results, and Who It's Actually For
By The RX Index Editorial Team
Published: · Last reviewed:
The honest bottom line
Zepbound (tirzepatide) is an FDA-approved weekly injection for chronic weight management, and separately for moderate-to-severe sleep apnea in adults with obesity. In the main approval trial, adults lost an average of about 15% to 21% of their body weight over 72 weeks. It's generally worth it for people who can access it affordably and are ready to treat weight as a long-term condition.
Short answer: for the right person, yes — and you've got more ways to make the money work than a year ago. But “worth it” isn't one answer for everyone. It comes down to three things most pages skip: what you'll actually pay (not the scary sticker price), whether you'll stay on it (because stopping has a catch), and whether your body and budget can handle it for the long haul.
Zepbound is likely worth it if you:
- Have obesity, or are overweight with a weight-related condition (high blood pressure, type 2 diabetes, or sleep apnea).
- Can pay for it long enough to give it a real shot (think months, not weeks).
- Are okay with a once-weekly shot under the skin.
- Want an FDA-approved option with very large average weight loss — one that beat Wegovy head-to-head.
Zepbound is probably not your first move if you:
- Have a personal or family history of medullary thyroid cancer (MTC) or MEN 2 — labeled contraindications.
- Are pregnant, could become pregnant, or planning pregnancy soon.
- Can't carry the monthly cost without real financial strain.
- Just want to drop a few pounds for an event.
- Are hoping a non-prescription supplement will do the same thing — it won't.
Is Zepbound worth it in 2026? The fast verdict
Zepbound is worth it when three things line up: it's medically right for you, you can access it at a price you can sustain, and you're prepared to treat obesity as the chronic condition it is. If any one of those breaks — usually price or safety fit — the value can fall apart fast.
| Your situation | Is Zepbound worth it? | Best next step |
|---|---|---|
| Insurance covers it and your copay is manageable | Usually yes — worth checking | Confirm prior-authorization and renewal rules |
| You're eligible for the Medicare GLP-1 Bridge | Potentially yes | Confirm the $50 copay path and covered product |
| You'd pay $299–$449/month cash | Maybe | Run the calculator; compare LillyDirect, Ro, Sesame |
| You'd pay $500–$700/month | Maybe — only if it's sustainable | Check every lower-cost path first |
| You'd pay $1,000+/month | Usually not your first move | Check coverage, savings card, and direct-pay options |
| You only want to lose a little, cosmetically | Usually no | Ask about lower-risk, lower-cost options |
| MTC/MEN 2 applies to you | No — labeled contraindication | Don't use Zepbound; ask a clinician about other options |
If the monthly cost is your dealbreaker, don't force it. Use The RX Index's Find My GLP-1 Path tool to get matched with lower-cost treatment paths instead.
How much does Zepbound actually cost in 2026?
Zepbound's full list price runs up to $1,086.37 a fill — but almost no one needs to pay that. With insurance plus the savings card it can be as low as $25 a fill; paying cash through LillyDirect or the new TrumpRx site it's $299–$449 a month; and starting mid-2026, eligible Medicare members can get it for a $50 copay. The price you'll actually pay depends entirely on your coverage.
Publicly listed prices verified June 2026. See Sources for each. *18-month totals are illustrations only. Your real number depends on your dose, refill timing, and coverage. We use 18 months because that's about the length of the trials.
| How you pay | Who it fits | What it costs | ~18-mo total* | The catch |
|---|---|---|---|---|
| Commercial insurance covers + savings card | A plan that covers obesity or sleep-apnea meds | As low as $25 per fill | ~$450 | Savings card caps at $100/mo and $1,300/yr in 2026 |
| Commercial insurance doesn't cover + savings card | A plan that excludes weight-loss meds | Single-dose pen: as low as ~$499/mo. KwikPen: $299 / $399 / $449 by dose | ~$5,400–$9,000 | Your price depends on the product and savings-card eligibility |
| LillyDirect or TrumpRx self-pay | Anyone with a valid prescription, paying cash | $299 (2.5 mg) · $399 (5 mg) · $449 (7.5–15 mg) | ~$7,800 | Refill within 45 days or higher doses jump to ~$499–$699 |
| Medicare GLP-1 Bridge (from July 1, 2026) | Eligible Medicare members; KwikPen, weight-management use | $50 copay | ~$900 | New program; sleep-apnea use goes through Part D, not the Bridge |
| Retail cash, no program | — | Up to $1,086.37 a fill | ~$19,500 | Usually not your first option |
| Through Ro *(adds provider + insurance help)* | People who need a prescriber or prior-auth help | Membership $39 first month, then $149/mo — or as low as $74/mo on the annual plan. Medication billed separately. | Membership ~$1,300–$2,600 + medication | Membership doesn't include the drug — you still pay for Zepbound |
The savings card. Eli Lilly offers a card that, for people with commercial insurance that covers Zepbound, drops the cost to as low as $25 a fill. For 2026, the card caps savings at $100 a month and $1,300 a year — lower than 2025, so if your bill went up in January, you're not imagining it. Medicare, Medicaid, TRICARE, VA, and other government plans can't use the commercial card, and some states have extra restrictions.
LillyDirect self-pay. Lilly selling straight to you. As of February 23, 2026, single-dose vials and the KwikPen run $299 (2.5 mg), $399 (5 mg), and $449 for every dose from 7.5 mg up — if you refill within 45 days of your last delivery. Miss that window and the price jumps to roughly $499 (7.5 mg) or $699 (10–15 mg). Set a phone reminder for day 30.
TrumpRx. The government's new drug-pricing site lists Zepbound starting at $299, then hands you off to LillyDirect to complete the order — same medication, same prices.
Prior authorization (when insurance makes your doctor prove you need a drug before it'll pay). This is the single biggest reason people give up on covered Zepbound. A provider with an insurance team that handles the paperwork can be the difference between $25 and $500.
Our honest read by price tier
| If your real cost lands at... | Our honest read |
|---|---|
| $25–$150/month | Usually worth a serious conversation with a clinician — if you qualify and no safety warnings apply. |
| $299–$449/month | Worth considering, if you can carry that cost for the long haul. |
| $500–$700/month | Maybe — but check every legitimate lower-cost path first. |
| $1,000+/month | Usually not your first move. Almost no one needs to pay full retail. |
Don't guess your price from a forum thread.
Ro's free GLP-1 Insurance Coverage Checker shows whether your plan may cover brand-name Zepbound, and their insurance team files the prior-authorization paperwork for you.
Check my Zepbound coverage on Ro → (sponsored affiliate link, opens in a new tab)Partner link.
Try it: the Zepbound Worth-It Calculator
Run your own numbers. Answer a few quick questions and get your likely monthly cost, a realistic weight-loss range from the trials, your 18-month total, and a plain-language verdict — worth checking, worth considering, or probably not your first move — with the right next step for your situation.
Inputs: current weight · insurance status (commercial / Medicare / cash / unsure) · monthly budget · safety flag (MTC/MEN 2). Outputs: likely monthly cost and 18-month total · realistic weight-loss range (SURMOUNT-1 averages) · plain-language verdict · your best next step. The math uses your first-dose monthly price; prices verified June 2026. These are estimates, not medical or financial advice. Only a licensed clinician can decide if Zepbound is right for you.
Answer a few quick questions and get your likely monthly cost, a realistic weight-loss range from the trials, your estimated 18-month total, and a plain-language verdict with your best next step. These are estimates, not medical or financial advice.
Do you have a personal or family history of medullary thyroid cancer (MTC) or MEN 2 syndrome?
How much weight can you really lose on Zepbound?
In SURMOUNT-1, the main trial behind Zepbound's approval (published in The New England Journal of Medicine), adults lost an average of about 15% of their body weight on the lowest dose, 19.5% on the middle dose, and 20.9% on the top dose over 72 weeks — and people who took it exactly as directed lost up to 22.5%. Results vary from person to person, and these averages assume diet and activity changes too.
| Starting weight | ~15% loss (lower dose) | ~19.5% loss (mid dose) | ~21% loss (top dose) |
|---|---|---|---|
| 180 lb | ~27 lb | ~35 lb | ~38 lb |
| 220 lb | ~33 lb | ~43 lb | ~46 lb |
| 260 lb | ~39 lb | ~51 lb | ~55 lb |
| 300 lb | ~45 lb | ~59 lb | ~63 lb |
For context: in the only head-to-head trial against Wegovy (SURMOUNT-5, also in NEJM), Zepbound came out ahead — an average 20.2% loss versus 13.7% for Wegovy, or about 50 pounds versus 33.
These are averages. Some people lose more, some less, and a small number stop early because of side effects. The trial result tells you what's possible, not what's promised.
Do you have to take Zepbound forever?
Not necessarily — but you shouldn't treat it like a short reset. In SURMOUNT-4 (published in JAMA), people who stopped tirzepatide after losing weight regained an average of 14% of their body weight over the next year, while those who kept taking it held onto their loss and lost a little more. In fact, 89.5% of people who continued kept at least 80% of their weight loss — versus just 16.6% of those who stopped.
| Your plan | What it means for “worth it” | What to nail down before you start |
|---|---|---|
| “I can stay on it, or follow a maintenance plan with my clinician.” | Strongest value case. | How you'll fund ongoing refills |
| “I can only afford one or two months.” | Weak value case — you likely won't see the full benefit, and you may regain. | Whether a short course is even worth starting (ask a clinician) |
| “I want a quick jump-start, then stop.” | Risky. Most people regain a big share. | A realistic maintenance plan, in writing |
| “I have no backup if my coverage stops.” | High financial and regain risk. | Your plan B before month one |
Zepbound is worth it the way blood-pressure medication is worth it — as ongoing care, not a cure you finish. If you go in with that mindset and a sustainable price, the value case is strong.
If you've decided Zepbound fits your life, the next step is simple. See current pricing and start a visit with a licensed provider who carries FDA-approved Zepbound.
See Zepbound pricing and start on Ro → (sponsored affiliate link, opens in a new tab)Partner link. Ro membership starts at $39, then as low as $74/month with annual prepay; medication is billed separately.
What are Zepbound's side effects — and who shouldn't take it?
Most side effects are stomach-related — nausea, diarrhea, constipation, and vomiting — usually mild to moderate, worst when your dose goes up, and easing over time. Zepbound also carries an FDA boxed warning for a risk of thyroid tumors seen in animal studies, plus several rarer but serious risks.
Common (reported in 5%+ of people):
Nausea, diarrhea, vomiting, constipation, belly pain, indigestion, injection-site reactions, tiredness, burping, hair loss, and acid reflux. Severe stomach reactions are uncommon but do rise with dose — about 1.7% at 5 mg, 2.5% at 10 mg, and 3.1% at 15 mg, versus 1% on placebo. Most people manage with slower dose increases, smaller low-fat meals, and plenty of fluids.
Two warnings that often get missed:
- Oral birth control. Zepbound slows how fast your stomach empties, which can affect how oral medications absorb. The label advises adding a barrier method or switching to a non-oral method for 4 weeks after starting and 4 weeks after each dose increase.
- Surgery and anesthesia. Tell your surgical or anesthesia team you take Zepbound before any planned procedure — the label warns about a risk of aspiration under general anesthesia or deep sedation.
Safety grid: dealbreaker or manageable?
Source: FDA-approved Zepbound label.
| Safety issue | What it means | Dealbreaker or manageable? | What to do |
|---|---|---|---|
| History of MTC or MEN 2 | A specific thyroid cancer / inherited gland syndrome | Dealbreaker — labeled contraindication | Don't use Zepbound; ask about other options |
| Serious allergic reaction to tirzepatide | — | Dealbreaker — labeled contraindication | Don't use Zepbound |
| Pregnant or planning pregnancy | Weight loss isn't recommended during pregnancy | Timing issue | Label says stop if you become pregnant; talk to a clinician first |
| You use oral birth control | Can affect how oral meds absorb | Manageable with a change | Add barrier method or switch to non-oral for 4 weeks after starting and after each dose increase |
| Common GI side effects | Usually mild–moderate, worst during dose increases | Usually manageable | Slower dose increases, smaller low-fat meals, fluids |
| Severe belly pain / gallbladder symptoms | Rare but serious | Call your doctor | Seek care promptly; don't wait |
| You take insulin or a sulfonylurea | Low-blood-sugar risk | Manageable with adjustment | Your clinician may lower those doses |
| Upcoming surgery or anesthesia | Aspiration risk under sedation | Manageable with planning | Tell your surgical/anesthesia team you take Zepbound |
| Severe stomach disease / gastroparesis | Slowed stomach emptying | Often a no | Not recommended; discuss with a clinician |
Is Zepbound worth it compared to Wegovy, Ozempic, and the new pills?
On weight loss alone, Zepbound has the edge — in the only head-to-head trial it beat Wegovy 20.2% to 13.7%. But “better” depends on what your insurance covers, how you tolerate each one, whether you want a shot or a pill, and your medical history.
| Option | FDA status | Form | When it may be the better pick |
|---|---|---|---|
| Zepbound (tirzepatide) | FDA-approved (weight; sleep apnea with obesity) | Weekly shot | Strongest average weight loss; sleep-apnea relevance |
| Wegovy (semaglutide) | FDA-approved (weight) | Weekly shot (and a pill) | If your plan covers Wegovy better, or you prefer semaglutide |
| Ozempic (semaglutide) | FDA-approved (type 2 diabetes) | Weekly shot | If you have diabetes and that's what's covered |
| Foundayo (orforglipron) | FDA-approved (weight) | Daily pill | If you want an FDA-approved pill and no needles |
| Compounded tirzepatide | Not FDA-approved as a finished drug | Varies | A separate, lower-cost decision — not the same as Zepbound |
Is Zepbound worth it without insurance?
Yes, for many cash-pay patients it now can be. LillyDirect and TrumpRx put authentic Zepbound at $299–$449 a month — a fraction of the up-to-$1,086 retail list price — with no insurance required. The catch is the 45-day refill rule that keeps the lowest price, and the fact that it's an ongoing cost.
Vials vs the KwikPen. The cheapest path is single-dose vials, which you draw up with a syringe. The KwikPen launched at self-pay pricing in February 2026 and now matches vial prices — easier to use, same cost for most doses. See our KwikPen guide.
The 45-day rule. It's the most common way people accidentally pay more. Refill within 45 days of your last delivery to hold the $449 (and lower) pricing.
A prescriber is still required. Zepbound is prescription-only. If you already have a doctor who'll write it, LillyDirect alone is usually your cheapest route. If you don't, a telehealth provider like Ro adds a licensed clinician and ships to your door.
For the full lowest-cost breakdown, see our guide to the cheapest legitimate ways to get Zepbound without insurance.
Begin a cash-pay Zepbound visit on Ro → (sponsored affiliate link, opens in a new tab)Partner link. Ro will check coverage first in case you qualify for less.
Is Zepbound worth it on Medicare in 2026?
For eligible Medicare members, the value math is about to change. The Medicare GLP-1 Bridge is scheduled to begin July 1, 2026 and run through December 31, 2027, offering Zepbound (the KwikPen) for a $50 monthly copay for those who qualify. Standard Medicare Part D has historically not covered weight-loss drugs, so this is a meaningful shift.
Weight management vs. sleep apnea: The Bridge is aimed at weight-management use. If you'd take Zepbound for moderate-to-severe sleep apnea, that's generally handled through standard Part D instead of the $50 Bridge route.
Don't rush: If Medicare is part of your decision, confirm the eligibility details before starting a cash-pay program you might not need after July. A $449 decision can become a $50 one.
We track the specifics in our Medicare GLP-1 Bridge eligibility guide.
Is Zepbound worth it for sleep apnea?
It may be especially worth discussing if you have obesity and moderate-to-severe obstructive sleep apnea (OSA), because Zepbound is FDA-approved to treat OSA in adults with obesity — the first medication ever approved for it. In the SURMOUNT-OSA trials, Zepbound reduced the number of breathing interruptions per hour (the AHI), and a large share of patients improved dramatically.
| Group | Reached remission or only mild OSA with no symptoms (1 year) | On placebo |
|---|---|---|
| Adults not using a CPAP machine | ~42% | ~16% |
| Adults using a CPAP machine | ~50% | ~14% |
Because Zepbound has a separate FDA-approved use for sleep apnea, an OSA diagnosis can change your coverage picture — some plans treat it differently than a weight-loss-only prescription. It's not a CPAP replacement, and you'd coordinate it with your sleep doctor. But if OSA is part of your story, raise it — it can tip both the medical and the financial case toward “yes.”
See our best GLP-1 for sleep apnea guide for the full coverage and clinical breakdown.
What if insurance denies Zepbound?
If insurance denies Zepbound, don't give up or pay full retail right away. A denial is often a paperwork problem — not a final no — and many denials are overturned on appeal with the right documentation.
- 1Read the denial. It will name a reason — missing prior authorization, a step-therapy rule (try a cheaper drug first), or a plan that excludes weight-loss meds entirely.
- 2Fix the paperwork. If prior authorization or an appeal is missing, that's the highest-leverage fix. This is exactly what a provider's insurance team does.
- 3Compare cash paths. While you appeal, price out the savings card, LillyDirect, and TrumpRx so you're never stuck at retail.
- 4Decide your route. If you want someone to fight the appeal for you, a telehealth provider with an insurance concierge is the cleanest path.
Denied, and not sure what to do next? Ro's insurance concierge files prior-authorization and appeal paperwork for you — and if coverage still doesn't come through, they'll point you to an FDA-approved cash-pay option.
Get insurance help from Ro → (sponsored affiliate link, opens in a new tab)Partner link. Membership starts at $39, then as low as $74/month with annual prepay; medication is billed separately.
What real people say about whether it was worth it
Patient accounts converge on a few honest themes: the appetite change can be dramatic, the cost is the hardest part, and the side effects are unpleasant but often manageable. The same three worries come up again and again: the money, the side effects, and “will I need this forever?” That's exactly why this page exists.
One patient who documented his fifth month put the mechanism plainly — he's just not as hungry, and he eats less. No willpower hacks; the drug quieted the hunger. In the same post he was blunt about cost: it's expensive, and the only reason it worked for his budget was that insurance brought it to about $25 a month. (Source: a patient's public essay, “Zepbound, Starting Month 5.”)
These are individual experiences from public accounts — not typical results, and not medical advice. We don't paste cherry-picked testimonials; the FTC has penalized companies for fake ones. We'd rather earn your trust with what we can verify.
If Zepbound's worth it for you, where should you start?
If Zepbound seems worth it, your next move isn't “buy it” — it's to reach FDA-approved Zepbound through the lowest-friction legitimate path for your situation.
| Your situation | Best place to start | Why |
|---|---|---|
| You have insurance and might need prior-auth help | Ro *(partner)* | FDA-approved Zepbound, a free coverage checker, and an insurance team that files the paperwork |
| You want to choose your own provider | Sesame *(partner)* | A second FDA-approved path with a provider-choice model and Costco-member pricing on some brands |
| Your doctor already wrote the prescription | LillyDirect | Often the lowest cash price if you don't need a telehealth visit |
| You're not sure Zepbound is even the right path | Find My GLP-1 Path | A personalized match by state, budget, formulation, and coverage |
For FDA-approved, brand-name Zepbound, Ro is our primary pick — it carries Zepbound (and the new pill Foundayo), it has a free insurance checker, and its insurance concierge fights prior authorizations and submits the paperwork for you, which is the single hardest part of getting covered. Sesame is our strong secondary when you'd rather pick your own provider or want its broad branded formulary. If you already have a willing doctor, LillyDirect is usually cheapest. And if you're genuinely unsure Zepbound is right, start with the quiz, not a checkout page.
What to ask your doctor before you decide
The best Zepbound decision isn't just about price — it's about fit. Bring this short list to your visit so you leave with a real plan, not just a prescription.
- Do I meet the FDA-labeled criteria for Zepbound?
- Do any contraindications or warnings apply to me (thyroid history, pancreatitis, severe stomach disease)?
- How should I think about pregnancy timing, and do I need backup birth control if I use the pill?
- Which side effects should make me call you?
- What happens if I can't tolerate a dose increase?
- How long should I expect to stay on it, and what's the maintenance plan?
- What's my plan if insurance stops covering it?
- Is another FDA-approved option a better fit for me?
How we scored this decision
The RX Index Score rates GLP-1 providers and treatment paths on five things, in this order: clinical legitimacy, care quality, transparency, access, and cost. For this page, our verdict is based on whether Zepbound's likely benefit justifies your likely cost, access friction, and long-term commitment — not on who pays us.
What we actually verified (June 2026):
- Zepbound's FDA approvals for chronic weight management and for moderate-to-severe sleep apnea — against the FDA and Eli Lilly.
- List price (up to $1,086.37 a fill), savings-card terms, and LillyDirect / TrumpRx self-pay pricing ($299/$399/$449) plus the 45-day refill rule — against Eli Lilly's published 2026 pages.
- Weight-loss results — against the SURMOUNT-1, SURMOUNT-4, and SURMOUNT-5 trials (NEJM and JAMA).
- The boxed warning, contraindications, and the contraception and anesthesia warnings — against the FDA-approved label.
- Ro's membership pricing and insurance-concierge details — against Ro.
- The Medicare GLP-1 Bridge timing, $50 copay, and weight-management-vs-Part-D distinction — against current CMS information.
Anything that's an editorial judgment — like “worth it for whom” — is our conclusion based on those verified facts, clearly labeled as such.
Frequently asked questions
Is Zepbound worth it for weight loss?
For many adults, yes. It produced very large average weight loss in trials - about 15% to 21% over 72 weeks in SURMOUNT-1 - and beat Wegovy in the SURMOUNT-5 head-to-head trial. It also has health benefits beyond weight, including a sleep-apnea indication. It's worth it for people who meet the criteria, can sustain the cost, and treat it as long-term care - not for casual, short-term use.
Is Zepbound worth the cost without insurance?
Often, yes - if the cash price works for you. Through LillyDirect or TrumpRx it runs $299-$449 a month, far below the up-to-$1,086 retail list price. If your only option is full retail, check insurance, the savings card, and direct-pay programs first.
Is Zepbound worth $500 a month?
It can be for someone with meaningful health stakes who can carry that cost - but at $500 you should first confirm you can't get it cheaper through insurance, the savings card, LillyDirect, or Medicare if eligible. Don't accept $500 before checking.
Is Zepbound worth it if my insurance covers it?
Usually, yes, if a clinician agrees it's appropriate and your copay is manageable - sometimes as low as $25 a fill with the savings card. The main hurdles become prior authorization and whether your plan keeps covering it.
How much weight can you lose on Zepbound?
In SURMOUNT-1, average weight loss over 72 weeks was about 15% (low dose), 19.5% (mid dose), and 20.9% (top dose), with up to 22.5% for those who took it as directed. Individual results vary.
Do you gain the weight back after stopping Zepbound?
Most people regain a significant share. In SURMOUNT-4, people who stopped regained an average of 14% of body weight within a year, while those who continued largely kept their results. Plan for ongoing treatment or a clinician-guided maintenance plan.
Is Zepbound better than Wegovy?
For weight loss, the head-to-head trial favored Zepbound (20.2% vs 13.7%). But better depends on coverage, side effects, form, and your health history - the right choice is the one your clinician approves and you can access.
Is Zepbound worth it for sleep apnea?
It may be, if you have obesity and moderate-to-severe obstructive sleep apnea - it's FDA-approved for that, and an OSA diagnosis can also affect insurance coverage. Coordinate it with your sleep doctor.
Who should not take Zepbound?
People with a personal or family history of medullary thyroid cancer (MTC) or MEN 2 should not use it - these are labeled contraindications. Pregnancy, certain stomach conditions, and other history should be reviewed with a clinician.
Is compounded tirzepatide the same as Zepbound?
No. Zepbound is FDA-approved; compounded GLP-1 drugs are not FDA-approved finished medications, and they should not be treated as equivalent. If you're considering compounded versions for cost, evaluate that as a separate decision.
What if my insurance denies Zepbound?
Check the denial reason first. If prior authorization or an appeal is missing, that's the highest-leverage fix, and a provider's insurance team can file it. While you appeal, compare the savings card, LillyDirect, and TrumpRx so you're never stuck at full retail.
Is Zepbound worth it at the 2.5 mg starting dose?
The 2.5 mg dose is a starting dose, not a maintenance dose. The full results in the trials came at higher doses, so plan (and budget) for moving up over time.
Is Zepbound worth it if I only need to lose 20 pounds?
Maybe not as a first step. It depends on your BMI and any weight-related conditions. If the goal is purely cosmetic and you don't meet the labeled criteria, lower-risk options usually make more sense - ask a clinician.
Sources
- U.S. Food and Drug Administration — Zepbound approval for chronic weight management (2023) and for moderate-to-severe obstructive sleep apnea (December 2024); FDA-approved prescribing information, boxed warning, contraindications, and the contraception and anesthesia warnings (label PDF: pi.lilly.com/us/zepbound-uspi.pdf).
- The New England Journal of Medicine — SURMOUNT-1 (tirzepatide for obesity, 2022); SURMOUNT-5 (tirzepatide vs semaglutide, 2025); SURMOUNT-OSA.
- JAMA and JAMA Internal Medicine — SURMOUNT-4 (continued treatment vs withdrawal, 2023) and the 2025 follow-up weight-regain analysis (jamanetwork.com/journals/jamainternalmedicine/fullarticle/2841273).
- Eli Lilly / LillyDirect — Zepbound list-price information (pricinginfo.lilly.com), Savings Card terms (zepbound.lilly.com), and Self Pay Journey pricing and 45-day refill terms (effective February 23, 2026).
- TrumpRx — Zepbound self-pay listing (hands off to LillyDirect).
- Ro (ro.co/weight-loss/zepbound/) — membership pricing and Zepbound access details, checked June 2026.
- Sesame — Zepbound and weight-loss program pricing, checked June 2026.
- Centers for Medicare & Medicaid Services — Medicare GLP-1 Bridge program (to be re-confirmed at the July 2026 launch).
Still not sure which GLP-1 program is right for you?
Take our free 60-second matching quiz to get a personalized provider match with source-verified pricing before you commit to anything.
Find My GLP-1 Path →Your situation changes the answer
Find My GLP-1 Path
The right GLP-1 provider isn't the same for everyone. It depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred route (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose.
- What it asks: your state, insurance situation, medication preference, budget, and support needs
- What you get: a personalized shortlist of GLP-1 providers matched to your situation, with verified pricing and the right questions to ask
- Cost: free · about 60 seconds · no signup